SCHEMBL9111658

SCHEMBL9111658

O=C1OC(=O)c2ccc3c4c(ccc1c24)C(Br)=C3Br

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TYMS P04818 5/20 0.50
ALOX15 P16050 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.35
NPC1 O15118 1/20 0.32
NSD2 O96028 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
AURKA O14965 1/20 0.32
AURKB Q96GD4 1/20 0.32
BCL2 P10415 1/20 0.31
PTPRC P08575 1/20 0.31
P2RX7 Q99572 1/20 0.31
S100A4 P26447 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148025 0.87 TYMS (0.62) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL502543 0.83 TYMS (0.48) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL30606666 0.77 TYMS (0.52) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL36626 0.77 TYMS (0.52) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL29349446 0.77 TYMS (0.52) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL15119575 0.77 TDP1 (0.65) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL13009255 0.77 TYMS (0.52) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL31185814 0.77 TYMS (0.52) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL127867 0.76 TSHR (0.54) TYMSALOX15TDP1ALDH1A1POLB
SCHEMBL128103 0.74 TYMS (0.41) TYMSALOX15TDP1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0683768-A1 UNSYMMETRICAL BIS-IMIDES AS ANTICANCER AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-11-29 EP disclosed
WO-1995008539-A1 IMPROVED METHODS FOR PREPARING BIS-IMIDE COMPOUNDS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-03-30 WO disclosed
US-5359070-A ANTITUMOR AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-25 US disclosed
WO-1994018171-A1 UNSYMMETRICAL BIS-IMIDES AS ANTICANCER AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-08-18 WO disclosed